Disseminated, fatal reactivation of bovine tuberculosis in a patient treated with adalimumab: a case report and review of the literature
Open Access
- 14 August 2024
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 53 (1) , 481-487
Abstract
Purpose: Tumor necrosis factor inhibitors (TNFi) are known to increase the risk of tuberculosis (TB) reactivation, though cases involving Mycobacterium bovis are rarely reported. Case presentation/results: We describe a case of disseminated TB with M. bovis in a 78-year-old woman with a negative Interferon-Gamma-Release Assay (IGRA), taking adalimumab due to rheumatoid polyarthritis, which resulted in a fatal outcome. The atypical clinical and histopathological features were initially interpreted as sarcoidosis. The case occurred in Switzerland, an officially bovine tuberculosis-free country. The whole genome sequence of the patient’s cultured M. bovis isolate was identified as belonging to the animal lineage La1.2, the main genotype in continental Europe, but showed significant genetic distance from previously sequenced Swiss cattle strains. In a literature review, four cases of bovine tuberculosis reactivation under TNFi treatment were identified, with pulmonal, oral and intestinal manifestations. Similar to our patient, two cases presented a negative IGRA before TNFi initiation, which later converted to positive upon symptomatic presentation of M. bovis infection. Conclusion: This case highlights the diagnostic challenges of TB in immunosuppressed patients, the limited sensitivity of IGRA, and the importance of considering TB reactivation even in regions declared free of bovine tuberculosis. Detailed patient histories, including potential exposure to unpasteurized dairy products, are essential for guiding preventive TB treatment before TNFi initiation.Keywords
Funding Information
- University of Basel
This publication has 20 references indexed in Scilit:
- Mycobacterial Infections Potentiated by BiologicsInfectious Disease Clinics of North America, 2020
- Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysisScientific Reports, 2020
- Zoonotic tuberculosis in human beings caused by Mycobacterium bovis—a call for actionThe Lancet Infectious Diseases, 2017
- Reactivación de infección por Mycobacterium bovis, e inhibidores del factor de necrosis tumoral. El caso de MéxicoArchivos de Bronconeumología, 2016
- Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysisEuropean Respiratory Journal, 2010
- Tuberkulosereaktivierung mit Mycobacterium-bovis-Infektion der Mundschleimhaut unter ImmunsuppressionDMW - Deutsche Medizinische Wochenschrift, 2010
- Re-activation of bovine tuberculosis in a patient treated with infliximab: Table 1—European Respiratory Journal, 2008
- Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the LungsInfection and Immunity, 2008
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995